Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05942248 · ClinicalTrials.gov registry record · NA

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

A NA study of Acne and Rosacea, sponsored by Integrative Skin Science and Research.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05942248 is a NA study of Acne and Rosacea that is actively recruiting participants, run by Integrative Skin Science and Research. The registered enrollment target is 150 participants, roughly in line with the 137-participant average among 26 other Acne trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05942248, a NA study of Acne and Rosacea, is actively recruiting participants, sponsored by Integrative Skin Science and Research.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.

Interventions

  • OTHER No Intervention

Study Locations (1)

California

  • Integrative Skin and Research - Sacramento

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-06-06
Est. Completion 2025-02-28
Phase NA

What the Registry Record Tells You About NCT05942248

The ClinicalTrials.gov registry entry for NCT05942248 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 137-participant average among 26 other Acne trials with a reported enrollment target. The listed sponsor is Integrative Skin Science and Research, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT05942248 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05942248 about?

NCT05942248 is a clinical study titled "The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis". The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.

What is the current status of trial NCT05942248?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-06-06. Estimated completion is 2025-02-28.

What conditions does trial NCT05942248 study?

This clinical trial studies the following conditions: Acne, Rosacea, Melasma, Seborrheic Dermatitis.

What interventions are being tested in trial NCT05942248?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT05942248?

This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05942248 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.